Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial

Anti-infective treatment of pulmonary exacerbations is a major issue in people with cystic fibrosis (CF). Individualized dosing strategies and adaptation of infusion times are important concepts to optimize anti-infective therapy. In this prospective non-randomized controlled open-label trial, we co...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antibiotics (Basel)
Main Authors: Kamp, Jan C., Fuge, Jan, Ringshausen, Felix C., Grote-Koska, Denis, Brand, Korbinian, Graalmann, Lukas, Vonberg, Ralf-Peter, Welte, Tobias, Rademacher, Jessica
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7998425/
https://ncbi.nlm.nih.gov/pubmed/33799542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10030292
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares